These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 8833225)
1. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225 [TBL] [Abstract][Full Text] [Related]
2. Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine. Hoshi K; Ma T; Oh S; Ho IK Brain Res; 1997 Apr; 753(1):63-8. PubMed ID: 9125432 [TBL] [Abstract][Full Text] [Related]
3. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats. Feng Y; Rockhold RW; Ho IK J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416 [TBL] [Abstract][Full Text] [Related]
4. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Sinchaisuk S; Ho IK; Rockhold RW Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173 [TBL] [Abstract][Full Text] [Related]
5. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Feng YZ; Zhang T; Rockhold RW; Ho IK Neurochem Res; 1995 Jun; 20(6):745-51. PubMed ID: 7566372 [TBL] [Abstract][Full Text] [Related]
6. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513 [TBL] [Abstract][Full Text] [Related]
7. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine. Wongchanapai W; Tsang BK; He Z; Ho IK Pharmacol Biochem Behav; 1998 Aug; 60(4):899-907. PubMed ID: 9700974 [TBL] [Abstract][Full Text] [Related]
8. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus. Hoshi K; Ma T; Ho IK Eur J Pharmacol; 1996 Oct; 314(3):301-6. PubMed ID: 8957250 [TBL] [Abstract][Full Text] [Related]
9. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956 [TBL] [Abstract][Full Text] [Related]
10. Opioid antagonists and butorphanol dependence. Jaw SP; Hoskins B; Ho IK Pharmacol Biochem Behav; 1993 Mar; 44(3):497-500. PubMed ID: 8383850 [TBL] [Abstract][Full Text] [Related]
11. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Hyytiä P; Kiianmaa K Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711 [TBL] [Abstract][Full Text] [Related]
12. The role of opioid receptors in morphine withdrawal in the infant rat. McPhie AA; Barr GA Brain Res Dev Brain Res; 2000 Nov; 124(1-2):73-80. PubMed ID: 11113514 [TBL] [Abstract][Full Text] [Related]
13. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958 [TBL] [Abstract][Full Text] [Related]
14. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons. Chieng B; Connor M; Christie MJ Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906 [TBL] [Abstract][Full Text] [Related]
15. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome. Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441 [TBL] [Abstract][Full Text] [Related]
16. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Maldonado R; Negus S; Koob GF Neuropharmacology; 1992 Dec; 31(12):1231-41. PubMed ID: 1335131 [TBL] [Abstract][Full Text] [Related]
17. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. Funada M; Schutz CG; Shippenberg TS Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160 [TBL] [Abstract][Full Text] [Related]
18. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord. Catheline G; Le Guen S; Besson JM Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048 [TBL] [Abstract][Full Text] [Related]
19. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
20. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats. Tokuyama S; Ho IK Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]